Astrana Health

Q2 FY2026 EarningsQ2 FY26 results were mixed relative to consensus: revenue reached $972.5M, slightly missing the $985.2M estimate (-1.3%), and GAAP operating income of $34.3M fell short of the $43.3M expectation (-20.7%) due to higher utilization in the Care Partners segment. However, Adjusted EPS of $0.80 beat the $0.73 consensus (+9.6%), primarily supported by a lower effective tax rate of 32.4% vs. 37.6% expected and a surge in Care Enablement profitability. The Prospect acquisition continues to drive top-line growth, contributing $281.5M in the quarter, though integration and non-routine legal costs weighed on GAAP margins.